Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.

Inclusion Criteria: * Diminution of vision due to diabetic macular edema. * CMT ≥ 250 µ. * Willing to participate in the study. Exclusion Criteria: * Unwilling to participate in the study, 2) * Ischemic RVO, * previous laser treatment * Glaucoma, macular ischemia, cataract, vitreous hemorrhage, and neovascularization of the iris, * patients with previous anti VEGFs or steroid injections or any eye surgery three months before the inclusion, * Cardiac co-morbidities result in significant hemodynamic changes, 7)Respiratory diseases need treatment with antibiotics, * Suffering from other chronic diseases as diabetes, * Patient with allergy from triamcinolone acetonide.